Research Data Package definition

Research Data Package means, with respect to each Research Compound, all Information and data to be provided to Takeda at the conclusion of the applicable Research Plan, the contents of which shall be agreed to by the Parties pursuant to the governance set forth in the Research Agreement.
Sample 1Sample 2
Research Data Package has the meaning set forth in Section 2.6.
Sample 1
Research Data Package means, on a Research Program-by-Research Program basis, a data package prepared by Ambrx with respect to Research activities conducted by or on behalf of Ambrx for such Research Program and associated Compounds and provided to BeiGene at the time identified in the applicable Research Plan. Each Research Data Package shall contain (a) the identity of the applicable Research Program, (b) a list of all then identified associated Compounds, (c) the identification of any Compounds that Ambrx reasonably believes meet the PCC Criteria and (d) all other information for such Research Program and associated Compound(s) outlined in the applicable Research Plan.
Sample 1

Examples of Research Data Package in a sentence

  • Research Data Package (CRDP), which will essentially be the first version of the ECV GHG.

  • It forms part of the first version of their Climate Research Data Package (CRDP v1).

  • The PUG provides the description of the Climate Research Data Package (CRDP).

  • References‌ Buchwitz et al., 2017: ESA Climate Change Initiative (CCI) Product Validation and Intercomparison Report (PVIR) for the Essential Climate Variable (ECV) Greenhouse Gases (GHG) for data set Climate Research Data Package No. 4 (CRDP#4), Version 5.0, 9.

  • Zehner: Quality assessment of the Ozone_cci Climate Research Data Package (release 2017): 2.

  • It forms part of the second version of their Climate Research Data Package (CRDP v2).

  • In this work, the Essential Climate Variable (ECV) Climate Research Data Package Total Ozone Column (CRDP TOC), refined and updated via the European Space Agency’s Climate Change Initiative Phase-II, is presented and validated against independent ground-based TOC observations.

  • Soc., 129, 1663-1681, 2003.[RD-19] Garane, K., Lerot, C., Coldewey-Egbers, M., Verhoelst, T., Koukouli, M.E., Zyrichidou, I., Balis, D.S., Danckaert, T., Goutail, F., Granville, J., Hubert, D., Keppens, A., Lambert, J.-C., Loyola, D., Pommereau, J.-P., Van Roozendael, M., and Zehner, C.: Quality assessment of the Ozone_cci Climate Research Data Package (release 2017) – Part 1: Ground-based validation of total ozone column data products, Atmos.

  • Material and methodIn this chapter, the conditions of experimentation, testing, and methods of analysis shall be described in the description of materials and methods related to tests, monographic analyses.

  • The main goal of the RR was to identify for each of the four core products which algorithms should be used to generate the Climate Research Data Package (CRDP).

Related to Research Data Package

  • Research Data means documents in a digital form, other than scientific publications, which are collected or produced in the course of scientific research activities and are used as evidence in the research process, or are commonly accepted in the research community as necessary to validate research findings and results;

  • Data Package has the meaning set forth in Section 2.9(a).

  • Development Data means all non-clinical, clinical, technical, chemical, safety, and scientific data and information and other results, including relevant laboratory notebook information, screening data, and synthesis schemes, including descriptions in any form, data and other information, in each case, that is generated by or resulting from or in connection with the conduct of Development of Products, to the extent that the same are Controlled by or in Adapt’s or its Affiliates’ or Adapt’s Commercial Sublicensees’ possession, and may be disclosed to Lightlake without violating any obligation under Applicable Law.

  • Clinical Data means the information concerning the safety or performance that is generated from the use of a device and that are sourced from the following:

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Research Results means any technical result acquired based on the Collaborative Research, including, but not limited to, any invention, idea, design, copyrightable work and know-how which relates to the purpose of the Collaborative Research.

  • Program Materials means the documents and information provided by the Program Administrator specifying the qualifying EEMs, technology requirements, costs and other Program requirements, which include, without limitation, program guidelines and requirements, application forms and approval letters.

  • Licensed Compound means [***].

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Program means the implementation of the development plan.

  • Study Data shall have the meaning set forth in Section 8.1.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Development Works means the external development works and internal development works on immovable property;

  • Research Program has the meaning set forth in Section 2.1.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams, and other information furnished by the Contractor to illustrate materials or equipment for some portion of the Work.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.